Yin X N, Zhang Q, He X L, Zhao M
Department of Pathology, Hangzhou Women's Hospital, Hangzhou 310008, China.
Department of Urology, Zhejiang Provincial People's Hospital & People's Hospital of Hangzhou Medical College, Hangzhou 310014, China.
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):317-323. doi: 10.3760/cma.j.cn112151-20190721-00405.
To investigate the clinicopathologic features, diagnosis and differential diagnosis of large nested variant of urothelial carcinoma (LNUC) of urinary bladder. The clinical and pathologic data of five cases of LNUC of urinary bladder diagnosed between January 2014 and December 2018 at the Department of Pathology, Zhejiang Provincial People's Hospital were analyzed by immunohistochemistry (IHC) and Sanger sequencing. The relevant literature was reviewed. All five patients were male with a mean age of 63 years (range, 48 to 81 years). The mean tumor size was 3.4 cm (range, 1.7 to 4.7 cm). Histologically, the invasive LNUC tumor cells formed medium to large sized nests of varying shapes, from regular round, bulbous, oval to irregularly fused, branched, dumbbell shaped glands, with mild stromal reaction. In all five cases, focal central necrosis and microcystic changes in the tumor nests were identified. Cytologically, the tumor cells were low grade in four cases; the remaining case was overall low grade with focal high grade areas. Mitoses were scarce. All cases possessed surface urothelial tumors, including three low-grade papillary carcinomas, one high-grade papillary carcinoma and one carcinoma in situ. Three of the LNUC were accompanied by small nested variant of urothelial carcinoma and two by conventional high grade invasive urothelial carcinoma. Perineural involvement and angiolymphatic invasion were each noted in four tumors. Radical cystectomy was performed in four cases with TNM stages as followings: pT3aN0M0 in two cases, pT4aN0M0 and pT4aN1M0 in one case each. The remaining case had transurethral bladder resection and was of pT2 stage. By IHC, all five cases were positive for CK7 and p40; four were positive for GATA3; two were positive for CK20; and the mean Ki-67 proliferation index was 18%. TERT promoter mutation status were successfully performed in three cases, with one showing mutation (C228T) and two were wild type. All patients received postoperative chemotherapy. At a follow-up of 2 to 11 months, one patient died of unrelated causes, two patients developed metastases, and two were alive with no evidence of disease. LNUC is a histologic subtype of urothelial carcinoma with deceptively benign features but aggressive behavior, and appreciation of its unique infiltration patterns can aid in diagnosis and differential diagnosis. LNUC tends to coexist with small nested variant of urothelial carcinoma, suggesting these may represent different manifestations of the same urothelial carcinoma subtype.
探讨膀胱尿路上皮癌大巢状变异型(LNUC)的临床病理特征、诊断及鉴别诊断。对2014年1月至2018年12月间浙江省人民医院病理科诊断的5例膀胱LNUC患者的临床和病理资料进行免疫组织化学(IHC)及Sanger测序分析,并复习相关文献。5例患者均为男性,平均年龄63岁(范围48至81岁)。肿瘤平均大小为3.4 cm(范围1.7至4.7 cm)。组织学上,浸润性LNUC肿瘤细胞形成中等至大的巢状结构,形状各异,从规则圆形、球形、椭圆形到不规则融合、分支、哑铃形腺体,伴有轻度间质反应。5例均见肿瘤巢内局灶性中央坏死及微囊性改变。细胞学上,4例肿瘤细胞为低级别;其余1例总体为低级别,伴有局灶性高级别区域。核分裂象少见。所有病例均伴有膀胱尿路上皮肿瘤,包括3例低级别乳头状癌、1例高级别乳头状癌和1例原位癌。3例LNUC伴有尿路上皮癌小巢状变异型,2例伴有传统高级别浸润性尿路上皮癌。4例肿瘤可见神经侵犯和血管淋巴管侵犯。4例行根治性膀胱切除术,TNM分期如下:2例为pT3aN0M0,1例为pT4aN0M0,1例为pT4aN1M0。其余1例行经尿道膀胱切除术,为pT2期。免疫组化结果显示,5例CK7和p40均阳性;4例GATA3阳性;2例CK20阳性;平均Ki-67增殖指数为18%。成功检测3例患者的TERT启动子突变状态,1例显示突变(C228T),2例为野生型。所有患者术后均接受化疗。随访2至11个月,1例患者死于非相关原因,2例发生转移,2例无疾病证据存活。LNUC是尿路上皮癌一种组织学亚型,具有看似良性的特征但行为侵袭性,认识其独特的浸润模式有助于诊断及鉴别诊断。LNUC常与尿路上皮癌小巢状变异型共存,提示二者可能为同一尿路上皮癌亚型的不同表现形式。